ISKJ.ME
Price:
$70.24
Market Cap:
$5.73B
Public Joint-Stock Company 'Human Stem Cells Institute' operates as a biotech company primarily in Russia. The company engages in the drug discovery, research and development, and marketing of proprietary products and services in the field of regenerative medicine; bio-insurance; medical genetics, including reproductive genetics; gene therapy; and biopharmaceutics. It owns and operates Gemabank, a family cord blood stem cell bank in Russia and the CIS; and Reprobank, a reproductive cell and tissue bank for personal storage of reproductive cells and tissues, as well as a sperm/oocyte donation. The company also offers Neovasculgen, a gene-therapy drug for treatment of peripheral arterial disea...[Read more]
Industry
Biotechnology
IPO Date
2010-03-03
Stock Exchange
MCX
Ticker
ISKJ.ME
According to Public Joint-Stock Company "Human Stem Cells Institute"’s latest financial reports and current stock price. The company's current PE Ratio is 270.15. This represents a change of 132.34% compared to the average of 116.27 of the last 4 quarters.
The mean historical PE Ratio of Public Joint-Stock Company "Human Stem Cells Institute" over the last ten years is 99.70. The current 270.15 PE Ratio has changed 27.00% with respect to the historical average. Over the past ten years (40 quarters), ISKJ.ME's PE Ratio was at its highest in in the September 2020 quarter at 3.07K. The PE Ratio was at its lowest in in the September 2021 quarter at -483.85.
Average
99.70
Median
23.71
Minimum
-17.45
Maximum
790.30
Discovering the peaks and valleys of Public Joint-Stock Company "Human Stem Cells Institute" PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.91%
Maximum Annual PE Ratio = 790.30
Minimum Annual Increase = -166.02%
Minimum Annual PE Ratio = -17.45
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 35.90 | -35.94% |
| 2023 | 56.04 | -52.14% |
| 2022 | 117.09 | -85.18% |
| 2021 | 790.30 | 1.91% |
| 2020 | 39.34 | 241.43% |
| 2019 | 11.52 | -166.02% |
| 2018 | -17.45 | 107.61% |
| 2017 | -8.41 | -30.88% |
| 2016 | -12.16 | -20.03% |
| 2015 | -15.21 | -75.68% |
The current PE Ratio of Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
69.68
5-year avg
207.74
10-year avg
99.70
Public Joint-Stock Company "Human Stem Cells Institute"’s PE Ratio is
| Company | PE Ratio | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Public Joint-Stock Company "Human Stem Cells Institute" using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Public Joint-Stock Company "Human Stem Cells Institute" or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Public Joint-Stock Company "Human Stem Cells Institute"'s PE Ratio?
How is the PE Ratio calculated for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
What is the highest PE Ratio for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
What is the 3-year average PE Ratio for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
What is the 5-year average PE Ratio for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
How does the current PE Ratio for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) compare to its historical average?